Janux Therapeutics
JANX
JANX
121 hedge funds and large institutions have $1.59B invested in Janux Therapeutics in 2024 Q1 according to their latest regulatory filings, with 63 funds opening new positions, 24 increasing their positions, 29 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
17% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 29
43% less call options, than puts
Call options by funds: $3.76M | Put options by funds: $6.66M
Holders
121
Holding in Top 10
4
Calls
$3.76M
Puts
$6.66M
Top Buyers
| 1 | +$116M | |
| 2 | +$53.5M | |
| 3 | +$37.6M | |
| 4 |
O
OrbiMed
New York
|
+$36.1M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$28.2M |
Top Sellers
| 1 | -$62.5M | |
| 2 | -$29M | |
| 3 | -$6.78M | |
| 4 |
BlackRock
New York
|
-$2.56M |
| 5 |
Millennium Management
New York
|
-$2.49M |